Lexaria Bioscience (LEXX) EBITDA Margin Growth (5y) (2022 - 2026)
Lexaria Bioscience (LEXX) EBITDA Margin Growth (5y) (2022 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
Lexaria Bioscience |
7.17 Mn |
1.65 Mn |
20,000.00 |
| Date | Value |
|---|
| Feb 28, 2026 |
-658,602.00 |
| Aug 31, 2025 |
-23,999.00 |
| May 31, 2025 |
163,853.00 |
| Feb 28, 2025 |
113,806.00 |
| Nov 30, 2024 |
770,938.00 |
| Aug 31, 2024 |
-172,752.00 |
| May 31, 2024 |
-17,819.00 |
| Feb 29, 2024 |
698,170.00 |
| Nov 30, 2023 |
237,424.00 |
| Aug 31, 2023 |
-275,884.00 |
| May 31, 2023 |
-60,616.00 |
| Feb 28, 2023 |
-568,124.00 |
| Nov 30, 2022 |
55,099.00 |
